Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
VPM1002 (Tuberculosis BCG Based Vaccine) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global VPM1002 (Tuberculosis BCG Based Vaccine) market is projected to reach US$ 474.6 million in 2034, increasing from US$ 373.7 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Demand from 0-5 Years Old and 5-18 Years Old are the major drivers for the industry.
Japan is the largest BCG Vaccine market with about 30% market share. North America is follower, accounting for about 29% market share.The key manufacturers are Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL etc. Top 3 companies occupied about 77% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global VPM1002 (Tuberculosis BCG Based Vaccine) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Vakzine Projekt Management (VPM)
Serum Institute of India
Segment by Type
by Dosage
0.5ml Package
1ml Package
2ml Package
Other
by Type of Inoculator
Initial Vaccinate
Revaccination
0-5 Years Old
5-18 Years Old
18-45 Years Old
45-65 Years Old
≥65 Years Old
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the VPM1002 (Tuberculosis BCG Based Vaccine) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of VPM1002 (Tuberculosis BCG Based Vaccine), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the VPM1002 (Tuberculosis BCG Based Vaccine) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of VPM1002 (Tuberculosis BCG Based Vaccine) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, VPM1002 (Tuberculosis BCG Based Vaccine) introduction, etc. VPM1002 (Tuberculosis BCG Based Vaccine) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of VPM1002 (Tuberculosis BCG Based Vaccine) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
VPM1002 (Tuberculosis BCG Based Vaccine) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global VPM1002 (Tuberculosis BCG Based Vaccine) market is projected to reach US$ 474.6 million in 2034, increasing from US$ 373.7 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Demand from 0-5 Years Old and 5-18 Years Old are the major drivers for the industry.
Japan is the largest BCG Vaccine market with about 30% market share. North America is follower, accounting for about 29% market share.The key manufacturers are Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL etc. Top 3 companies occupied about 77% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global VPM1002 (Tuberculosis BCG Based Vaccine) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Vakzine Projekt Management (VPM)
Serum Institute of India
Segment by Type
by Dosage
0.5ml Package
1ml Package
2ml Package
Other
by Type of Inoculator
Initial Vaccinate
Revaccination
Segment by Application
0-5 Years Old
5-18 Years Old
18-45 Years Old
45-65 Years Old
≥65 Years Old
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the VPM1002 (Tuberculosis BCG Based Vaccine) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of VPM1002 (Tuberculosis BCG Based Vaccine), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the VPM1002 (Tuberculosis BCG Based Vaccine) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of VPM1002 (Tuberculosis BCG Based Vaccine) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, VPM1002 (Tuberculosis BCG Based Vaccine) introduction, etc. VPM1002 (Tuberculosis BCG Based Vaccine) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of VPM1002 (Tuberculosis BCG Based Vaccine) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices